BOLD compared with PLRX: revenue, margins and what each company keeps, and the suppliers and customers both name

BOLDBoundless Bio, Inc.

Mkt capRevenueRevenue

PLRXPliant Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

BOLDBoundless Bio, Inc.

PLRXPliant Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

BOLD, solidPLRX, dashed

Supply-chain overlap

Revenue flow

BOLD: latest quarter not drawable. PLRX: latest quarter is a loss; flow not drawable.Method ›

BOLDBoundless Bio, Inc.

2.45▼−1.21%· post 2.45

Mkt cap$56.2MRevenue—

PLRXPliant Therapeutics, Inc.

0.85▼−1.58%· post 0.85

ClosedOct 30 '26

Mkt cap$53.2MRevenue$248,000Q2 FY23

Compare

ClosedOct 30 '26

BOLDBoundless Bio, Inc.

PLRXPliant Therapeutics, Inc.

2.45▼−1.21%post 2.45

Price

0.85▼−1.58%post 0.85

$56.2M

Mkt cap

$53.2M

—

Revenue

$248,000Q2 FY23

BOLD2.45▼−1.21%vsPLRX0.85▼−1.58%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BOLD 0

None

Shared 0

No disclosed counterparties: BOLD.

Only PLRX 1

NVSNovartissupplier

Role chip = supplier or customerSource: SEC EDGAR